X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA
- chromosome 6 -
| Symbol | GoldenPath (Mb) | Location | Description |
|---|---|---|---|
| DUSP22 | 237.101 | 6p25.3 | dual specificity phosphatase 22 |
| IRF4 | 336.760 | 6p25-p23 | interferon regulatory factor 4 |
| EXOC2 | 430.139 | 6p25.3 | exocyst complex component 2 |
| HUS1B | 600.940 | 6p25.3 | HUS1 checkpoint homolog b (S. pombe) |
| FOXQ1 | 1257.675 | 6p25 | forkhead box Q1 |
| FOXF2 | 1335.068 | 6p25.3 | forkhead box F2 |
| FOXC1 | 1555.680 | 6p25 | forkhead box C1 |
| WRNIP1 | 2710.665 | 6p25.2 | Werner helicase interacting protein 1 |
| SERPINB9 | 2832.505 | 6p25 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
| NQO2 | 2945.066 | 6pter-q12 | NAD(P)H dehydrogenase, quinone 2 |
| RIPK1 | 3022.057 | 6p25.2 | receptor (TNFRSF)-interacting serine-threonine kinase 1 |
| TUBB2A | 3098.903 | 6p25 | tubulin, beta 2A |
| TUBB2B | 3169.514 | 6p25 | tubulin, beta 2B |
| PRPF4B | 3966.568 | 6p25.2 | PRP4 pre-mRNA processing factor 4 homolog B (yeast) |
| NRN1 | 5943.234 | 6p25.1 | neuritin 1 |
| F13A1 | 6089.310 | 6p25.3-p24.3 | coagulation factor XIII, A1 polypeptide |
| SSR1 | 7232.803 | 6p24.3 | signal sequence receptor, alpha (translocon-associated protein alpha) |
| CAGE1 | 7271.888 | 6p24.3 | cancer antigen 1 |
| RIOK1 | 7347.879 | 6p24.3 | RIO kinase 1 (yeast) |
| DSP | 7486.869 | 6p24 | desmoplakin |
| BMP6 | 7672.010 | 6p24-p23 | bone morphogenetic protein 6 |
| TXNDC5 | 7826.753 | 6p24.3 | thioredoxin domain containing 5 |
| EEF1E1 | 8024.638 | 6p24.3-p25.1 | eukaryotic translation elongation factor 1 epsilon 1 |
| HULC | 8597.440 | 6p24.3 | hypothetical protein LOC728655 |
| TFAP2A | 10504.903 | 6p24 | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| HPCQTL19 | 10779.641 | 19q | Prostate cancer aggressiveness quantitative trait locus on chromosome 19 |
| MAK | 10870.944 | 6p24 | male germ cell-associated kinase |
| NEDD9 | 11308.593 | 6p25-p24 | neural precursor cell expressed, developmentally down-regulated 9 |
| EDN1 | 12398.515 | 6p24.1 | endothelin 1 |
| RANBP9 | 13729.710 | 6p23 | RAN binding protein 9 |
| CD83 | 14225.844 | 6p23 | CD83 molecule |
| JARID2 | 15354.506 | 6p24-p23 | jumonji, AT rich interactive domain 2 |
| CAP2 | 17501.715 | 6p22.3 | CAP, adenylate cyclase-associated protein, 2 (yeast) |
| NUP153 | 17723.248 | 6p22.3 | nucleoporin 153kDa |
| TPMT | 18236.526 | 6p22.3 | thiopurine S-methyltransferase |
| DEK | 18332.381 | 6p22.3 | DEK oncogene (DNA binding) |
| LOC255519 | 18495.560 | 16q13 | similar to high-mobility group box 3 |
| RNF144B | 18495.573 | 6p22.3 | ring finger 144B |
| ID4 | 19945.596 | 6p22-p21 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
| E2F3 | 20510.377 | 6p22 | E2F transcription factor 3 |
| SOX4 | 21701.951 | 6p22.3 | SRY (sex determining region Y)-box 4 |
| PRL | 22395.459 | 6p22.2-p21.3 | prolactin |
| DCDC2 | 24279.963 | 6p22.1 | doublecortin domain containing 2 |
| MRS2 | 24511.132 | - | - |
| GPLD1 | 24581.307 | 6p22.3-p22.2 | glycosylphosphatidylinositol specific phospholipase D1 |
| TTRAP | 24758.185 | 6p22.3-p22.1 | TRAF and TNF receptor associated protein |
| GMNN | 24883.143 | 6p22.2 | geminin, DNA replication inhibitor |
| SCGN | 25760.408 | 6p22.3-p22.1 | secretagogin, EF-hand calcium binding protein |
| HIST1H1A | 26125.240 | 6p21.3 | histone cluster 1, H1a |
| HFE | 26195.488 | 6p21.3 | hemochromatosis |
| HIST1H2AC | 26232.352 | 6p21.3 | histone cluster 1, H2ac |
| BTS1 | 26608.550 | - | bladder tumor susceptibility 1 |
| HMGN4 | 26646.551 | 6p21.3 | high mobility group nucleosomal binding domain 4 |
| MAP2K1P1 | 26705.159 | 8p21 | mitogen-activated protein kinase kinase 1 pseudogene 1 |
| ECT2L | 26954.458 | - | epithelial cell transforming sequence 2 oncogene-like |
| RAB44 | 26954.458 | - | RAB44, member RAS oncogene family |
| HIST1H4I | 27215.067 | 6p21.33 | histone cluster 1, H4i |
| GPX5 | 28601.768 | 6p22.1 | glutathione peroxidase 5 (epididymal androgen-related protein) |
| TRIM27 | 28978.759 | 6p22 | tripartite motif-containing 27 |
| MAS1L | 29562.524 | 6p21 | MAS1 oncogene-like |
| GABBR1 | 29677.984 | 6p21.31 | gamma-aminobutyric acid (GABA) B receptor, 1 |
| HLA-G | 29903.497 | 6p21.3 | major histocompatibility complex, class I, G |
| HLA-A | 30018.310 | 6p21.3 | major histocompatibility complex, class I, A |
| ZNRD1 | 30137.015 | 6p21.3 | zinc ribbon domain containing 1 |
| PPP1R11 | 30142.911 | 6p21.3 | protein phosphatase 1, regulatory (inhibitor) subunit 11 |
| RNF39 | 30146.023 | 6p21.3 | ring finger protein 39 |
| TRIM26 | 30260.213 | 6p21.3 | tripartite motif-containing 26 |
| HLA-E | 30565.250 | 6p21.3 | major histocompatibility complex, class I, E |
| ABCF1 | 30647.149 | 6p21.33 | ATP-binding cassette, sub-family F (GCN20), member 1 |
| PPP1R10 | 30676.162 | 6p21.3 | protein phosphatase 1, regulatory (inhibitor) subunit 10 |
| RANP1 | 30722.988 | 6p21.33 | RAN, member RAS oncogene family pseudogene 1 |
| DHX16 | 30728.886 | 6p21.3 | DEAH (Asp-Glu-Ala-His) box polypeptide 16 |
| MDC1 | 30775.563 | 6p21.3 | mediator of DNA damage checkpoint 1 |
| TUBB | 30796.136 | 6p21.33 | tubulin, beta |
| IER3 | 30818.955 | 6p21.3 | immediate early response 3 |
| DDR1 | 30960.306 | 6p21.3 | discoidin domain receptor tyrosine kinase 1 |
| GTF2H4 | 30983.956 | 6p21.3 | general transcription factor IIH, polypeptide 4, 52kDa |
| VARS2 | 30989.961 | - | valyl-tRNA synthetase 2, mitochondrial (putative) |
| POU5F1 | 31240.094 | 6p21.31 | POU class 5 homeobox 1 |
| HLA-C | 31344.509 | 6p21.3 | major histocompatibility complex, class I, C |
| HLA-B | 31429.630 | 6p21.3 | major histocompatibility complex, class I, B |
| MICB | 31573.945 | 6p21.3 | MHC class I polypeptide-related sequence B |
| LTA | 31648.072 | 6p21.3 | lymphotoxin alpha (TNF superfamily, member 1) |
| TNF | 31651.329 | 6p21.3 | tumor necrosis factor (TNF superfamily, member 2) |
| LTB | 31656.317 | 6p21.3 | lymphotoxin beta (TNF superfamily, member 3) |
| LST1 | 31662.604 | 6p21.3 | leukocyte specific transcript 1 |
| NCR3 | 31664.651 | 6p21.3 | natural cytotoxicity triggering receptor 3 |
| AIF1 | 31691.768 | 6p21.3 | allograft inflammatory factor 1 |
| BAT3 | 31714.784 | 6p21.3 | HLA-B associated transcript 3 |
| CSNK2B | 31741.636 | 6p21-p12|6p21.3 | casein kinase 2, beta polypeptide |
| MSH5 | 31815.753 | 6p21.3 | mutS homolog 5 (E. coli) |
| HSPA1L | 31885.375 | 6p21.3 | heat shock 70kDa protein 1-like |
| HSPA1A | 31891.316 | 6p21.3 | heat shock 70kDa protein 1A |
| SKIV2L | 32034.560 | 6p21 | superkiller viralicidic activity 2-like (S. cerevisiae) |
| STK19 | 32047.625 | 6p21.3 | serine/threonine kinase 19 |
| CYP21A2 | 32114.061 | 6p21.3 | cytochrome P450, family 21, subfamily A, polypeptide 2 |
| TNXB | 32116.911 | 6p21.3 | tenascin XB |
| RNF5 | 32254.140 | 6p21.3 | ring finger protein 5 |
| AGER | 32256.724 | 6p21.3 | advanced glycosylation end product-specific receptor |
| PBX2 | 32260.488 | 6p21.3 | pre-B-cell leukemia homeobox 2 |
| NOTCH4 | 32270.599 | 6p21.3 | Notch homolog 4 (Drosophila) |
| HLA-DRA | 32515.625 | 6p21.3 | major histocompatibility complex, class II, DR alpha |
| HLA-DRB1 | 32654.525 | 6p21.3 | major histocompatibility complex, class II, DR beta 1 |
| HLA-DQA1 | 32713.161 | 6p21.3 | major histocompatibility complex, class II, DQ alpha 1 |
| HLA-DQB1 | 32735.635 | 6p21.3 | major histocompatibility complex, class II, DQ beta 1 |
| HLA-DOB | 32888.519 | 6p21.3 | major histocompatibility complex, class II, DO beta |
| TAP2 | 32897.588 | 6p21.3 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
| PSMB8 | 32916.477 | 6p21.3 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) |
| TAP1 | 32920.965 | 6p21.3 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
| PSMB9 | 32929.916 | 6p21.3 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) |
| BRD2 | 33044.415 | 6p21.3 | bromodomain containing 2 |
| HLA-DOA | 33079.940 | 6p21.3 | major histocompatibility complex, class II, DO alpha |
| HLA-DPB1 | 33151.738 | 6p21.3 | major histocompatibility complex, class II, DP beta 1 |
| COL11A2 | 33238.447 | 6p21.3 | collagen, type XI, alpha 2 |
| RXRB | 33269.344 | 6p21.3 | retinoid X receptor, beta |
| HSD17B8 | 33280.397 | 6p21.3 | hydroxysteroid (17-beta) dehydrogenase 8 |
| RING1 | 33284.264 | 6p21.3 | ring finger protein 1 |
| PFDN6 | 33365.356 | 6p21.3 | prefoldin subunit 6 |
| RGL2 | 33367.416 | 6p21.3 | ral guanine nucleotide dissociation stimulator-like 2 |
| TAPBP | 33379.396 | 6p21.3 | TAP binding protein (tapasin) |
| DAXX | 33394.379 | 6p21.3 | death-associated protein 6 |
| PHF1 | 33486.772 | 6p21.3 | PHD finger protein 1 |
| BAK1 | 33648.302 | 6p21.3 | BCL2-antagonist/killer 1 |
| ITPR3 | 33697.139 | 6p21 | inositol 1,4,5-triphosphate receptor, type 3 |
| IHPK3 | 33797.422 | 6p21.31 | inositol hexaphosphate kinase 3 |
| GRM4 | 34097.607 | 6p21.3 | glutamate receptor, metabotropic 4 |
| HMGA1 | 34312.628 | 6p21 | high mobility group AT-hook 1 |
| RPS10 | 34493.211 | 6p21.31 | ribosomal protein S10 |
| SPDEF | 34613.558 | 6p21.3 | SAM pointed domain containing ets transcription factor |
| DEF6 | 35373.573 | 6p21.33-p21.1 | differentially expressed in FDCP 6 homolog (mouse) |
| PPARD | 35418.313 | 6p21.2-p21.1 | peroxisome proliferator-activated receptor delta |
| FANCE | 35528.116 | 6p22-p21 | Fanconi anemia, complementation group E |
| RPL10A | 35544.156 | 6p21.3-p21.2 | ribosomal protein L10a |
| FKBP5 | 35649.346 | 6p21.3-p21.2 | FK506 binding protein 5 |
| SRPK1 | 35908.790 | 6p21.3-p21.2 | SFRS protein kinase 1 |
| MAPK14 | 36103.551 | 6p21.3-p21.2 | mitogen-activated protein kinase 14 |
| MAPK13 | 36206.240 | 6p21.31 | mitogen-activated protein kinase 13 |
| ETV7 | 36441.950 | 6p21 | ets variant gene 7 (TEL2 oncogene) |
| STK38 | 36569.650 | 6p21 | serine/threonine kinase 38 |
| SFRS3 | 36670.144 | 6p21 | splicing factor, arginine/serine-rich 3 |
| CDKN1A | 36754.465 | 6p21.2 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| PI16 | 37030.187 | 6p21.2 | peptidase inhibitor 16 |
| MTCH1 | 37043.896 | 6pter-p24.1 | mitochondrial carrier homolog 1 (C. elegans) |
| FGD2 | 37081.401 | 6p21.2 | FYVE, RhoGEF and PH domain containing 2 |
| PIM1 | 37245.964 | 6p21.2 | pim-1 oncogene |
| RNF8 | 37429.726 | 6p21.3 | ring finger protein 8 |
| GLO1 | 38751.682 | 6p21.3-p21.1 | glyoxalase I |
| GLP1R | 39124.595 | 6p21 | glucagon-like peptide 1 receptor |
| NFYA | 41148.688 | 6p21.3 | nuclear transcription factor Y, alpha |
| NCR2 | 41411.506 | 6p21.1 | natural cytotoxicity triggering receptor 2 |
| FOXP4 | 41622.142 | 6p21.1 | forkhead box P4 |
| HPFH | 41759.694 | 6q22.3-q23.1 | hereditary persistence of fetal hemoglobin, heterocellular |
| TFEB | 41759.695 | 6p21 | transcription factor EB |
| PGC | 41812.430 | 6p21.3-p21.1 | progastricsin (pepsinogen C) |
| PRICKLE4 | 41856.478 | 6p21.31 | prickle homolog 4 (Drosophila) |
| BYSL | 41996.943 | 6p21.1 | bystin-like |
| CCND3 | 42010.650 | 6p21 | cyclin D3 |
| TRERF1 | 42303.843 | 6p21.1-p12.1 | transcriptional regulating factor 1 |
| HCRP1 | 42434.507 | - | hepatocellular carcinoma-related HCRP1 |
| PRPH2 | 42772.318 | 6p21.2-p12.3 | peripherin 2 (retinal degeneration, slow) |
| TBCC | 42820.213 | 6pter-p12.1 | tubulin folding cofactor C |
| PTCRA | 42991.705 | 6p21.3 | pre T-cell antigen receptor alpha |
| GNMT | 43036.478 | 6p12 | glycine N-methyltransferase |
| PPP2R5D | 43060.308 | 6p21.1 | protein phosphatase 2, regulatory subunit B', delta isoform |
| CUL7 | 43113.334 | 6p21.1 | cullin 7 |
| PTK7 | 43152.007 | 6p21.1-p12.2 | PTK7 protein tyrosine kinase 7 |
| SRF | 43246.898 | 6p21.1 | serum response factor (c-fos serum response element-binding transcription factor) |
| PARC | 43257.900 | 6p21.1 | p53-associated parkin-like cytoplasmic protein |
| TTBK1 | 43319.200 | 6p21.1 | tau tubulin kinase 1 |
| ABCC10 | 43507.467 | 6p21.1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 10 |
| XPO5 | 43598.053 | 6p21.1 | exportin 5 |
| POLH | 43651.923 | 6p21.1 | polymerase (DNA directed), eta |
| MAD2L1BP | 43711.555 | 6p21.1 | MAD2L1 binding protein |
| VEGFA | 43845.931 | 6p12 | vascular endothelial growth factor A |
| SLC29A1 | 44299.274 | 6p21.2-p21.1 | solute carrier family 29 (nucleoside transporters), member 1 |
| HSP90AB1 | 44322.827 | 6p12 | heat shock protein 90kDa alpha (cytosolic), class B member 1 |
| NFKBIE | 44333.881 | 6p21.1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
| CDC5L | 44463.280 | 6p21 | CDC5 cell division cycle 5-like (S. pombe) |
| ST11 | 44904.447 | 3p25 | suppression of tumorigenicity 11 (pancreas) |
| SUPT3H | 44904.449 | 6p21.1-p21.3 | suppressor of Ty 3 homolog (S. cerevisiae) |
| RUNX2 | 45404.032 | 6p21 | runt-related transcription factor 2 |
| RCAN2 | 46296.428 | 6p12.3 | regulator of calcineurin 2 |
| MEP1A | 46869.053 | 6p12-p11 | meprin A, alpha (PABA peptide hydrolase) |
| TNFRSF21 | 47307.228 | 6p21.1-p12.2 | tumor necrosis factor receptor superfamily, member 21 |
| CRISP2 | 49768.031 | 6p21-qter | cysteine-rich secretory protein 2 |
| CRISP3 | 49803.056 | 6p12.3 | cysteine-rich secretory protein 3 |
| PGL2 | 49861.606 | 11q13.1 | paraganglioma or familial glomus tumors 2 |
| TFAP2B | 50894.398 | 6p12 | transcription factor AP-2 beta (activating enhancer binding protein 2 beta) |
| IL17A | 52159.144 | 6p12 | interleukin 17A |
| IL17F | 52209.443 | 6p12 | interleukin 17F |
| MCM3 | 52236.771 | 6p12 | minichromosome maintenance complex component 3 |
| TRAM2 | 52470.161 | 6p21.1-p12 | translocation associated membrane protein 2 |
| GSTA2 | 52723.140 | 6p12.1 | glutathione S-transferase A2 |
| GSTA1 | 52764.348 | 6p12.1 | glutathione S-transferase A1 |
| GSTA3 | 52869.404 | 6p12.1 | glutathione S-transferase A3 |
| GSTA4 | 52950.710 | 6p12.1 | glutathione S-transferase A4 |
| ICK | 52974.057 | 6p12.3-p11.2 | intestinal cell (MAK-like) kinase |
| GCLC | 53470.101 | 6p12 | glutamate-cysteine ligase, catalytic subunit |
| BMP5 | 55728.196 | 6p12.1 | bone morphogenetic protein 5 |
| DST | 56430.744 | 6p12.1 | dystonin |
| BAG2 | 57145.293 | 6p12.3-p11.2 | BCL2-associated athanogene 2 |
| RAB23 | 57161.550 | 6p11 | RAB23, member RAS oncogene family |
| PRIM2 | 57290.381 | 6p12-p11.1 | primase, DNA, polypeptide 2 (58kDa) |
| KHDRBS2 | 62447.824 | 6q11.1 | KH domain containing, RNA binding, signal transduction associated 2 |
| PTP4A1 | 64339.879 | 6q12 | protein tyrosine phosphatase type IVA, member 1 |
| BAI3 | 69402.353 | 6q12 | brain-specific angiogenesis inhibitor 3 |
| SMAP1 | 71434.200 | 6q13 | stromal membrane-associated GTPase-activating protein 1 |
| DDX43 | 74161.192 | 6q12-q13 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 |
| EEF1A1 | 74282.194 | 6q14.1 | eukaryotic translation elongation factor 1 alpha 1 |
| CD109 | 74462.235 | 6q13 | CD109 molecule |
| COX7A2 | 76004.223 | 6q12 | cytochrome c oxidase subunit VIIa polypeptide 2 (liver) |
| SENP6 | 76368.342 | 6q13-q14.3 | SUMO1/sentrin specific peptidase 6 |
| MYO6 | 76515.629 | 6q13 | myosin VI |
| HMGN3 | 79967.683 | 6q14.1 | high mobility group nucleosomal binding domain 3 |
| TTK | 80771.078 | 6q13-q21 | TTK protein kinase |
| FAM46A | 82512.167 | 6q14 | family with sequence similarity 46, member A |
| TPBG | 83130.258 | 6q14-q15 | trophoblast glycoprotein |
| NT5E | 86216.528 | 6q14-q21 | 5'-nucleotidase, ecto (CD73) |
| SNHG5 | 86443.516 | 6q14.3 | small nucleolar RNA host gene (non-protein coding) 5 |
| CGA | 87851.941 | 6q12-q21 | glycoprotein hormones, alpha polypeptide |
| ORC3L | 88356.562 | 6q14.3-q16.1 | origin recognition complex, subunit 3-like (yeast) |
| CNR1 | 88906.306 | 6q14-q15 | cannabinoid receptor 1 (brain) |
| UBE2J1 | 90093.064 | 6q15 | ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast) |
| RRAGD | 90134.313 | 6q15-q16 | Ras-related GTP binding D |
| CASP8AP2 | 90596.379 | 6q15 | CASP8 associated protein 2 |
| BACH2 | 90692.969 | 6q15 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
| MAP3K7 | 91282.074 | 6q16.1-q16.3 | mitogen-activated protein kinase kinase kinase 7 |
| EPHA7 | 94007.862 | 6q16.1 | EPH receptor A7 |
| TSG1 | 94473.521 | 6q16.1 | tumor suppressor TSG1 |
| C6orf66 | 97445.609 | 6q16.1 | chromosome 6 open reading frame 66 |
| POU3F2 | 99389.301 | 6q16 | POU class 3 homeobox 2 |
| SFRS18 | 99954.562 | 6q16.3 | splicing factor, arginine/serine-rich 18 |
| CCNC | 100096.985 | 6q21 | cyclin C |
| HACE1 | 105282.661 | 6q21 | HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 |
| LIN28B | 105511.616 | 6q21 | lin-28 homolog B (C. elegans) |
| AIM1 | 107066.423 | 6q21 | absent in melanoma 1 |
| QRSL1 | 107184.146 | 6q21 | glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 |
| PDSS2 | 107580.456 | 6q21 | prenyl (decaprenyl) diphosphate synthase, subunit 2 |
| SEC63 | 108298.216 | 6q21 | SEC63 homolog (S. cerevisiae) |
| SNX3 | 108639.411 | 6q21 | sorting nexin 3 |
| FOXO3 | 108987.719 | 6q21 | forkhead box O3 |
| FOXO1B | 108987.719 | 5q35.2-q35.3 | forkhead box O1B pseudogene |
| FOXO3B | 108987.719 | 17p11 | forkhead box O3B pseudogene |
| SESN1 | 109414.340 | 6q21 | sestrin 1 |
| CD164 | 109794.416 | 6q21 | CD164 molecule, sialomucin |
| SLC22A16 | 110852.603 | 6q22.1|6q21-q22.1 | solute carrier family 22 (organic cation/carnitine transporter), member 16 |
| CDC2L6 | 111037.874 | 6q21 | cell division cycle 2-like 6 (CDK8-like) |
| AMD1 | 111302.680 | 6q21-q22 | adenosylmethionine decarboxylase 1 |
| REV3L | 111726.927 | 6q21 | REV3-like, catalytic subunit of DNA polymerase zeta (yeast) |
| TRAF3IP2 | 111986.838 | 6q21 | TRAF3 interacting protein 2 |
| FYN | 112089.180 | 6q21 | FYN oncogene related to SRC, FGR, YES |
| WISP3 | 112487.909 | 6q21 | WNT1 inducible signaling pathway protein 3 |
| LAMA4 | 112535.827 | 6q21 | laminin, alpha 4 |
| MACSL1 | 114285.249 | - | myristoylated alanine-rich protein kinase C substrate (MARCKS, 80K-L)-like 1 |
| HDAC2 | 114364.022 | 6q21 | histone deacetylase 2 |
| FRK | 116369.387 | 6q21-q22.3 | fyn-related kinase |
| DSE | 116798.803 | 6q22 | dermatan sulfate epimerase |
| KPNA5 | 117109.060 | 6q22.2 | karyopherin alpha 5 (importin alpha 6) |
| ROS1 | 117716.223 | 6q22 | c-ros oncogene 1 , receptor tyrosine kinase |
| GOPC | 117988.128 | 6q21 | golgi associated PDZ and coiled-coil motif containing |
| ASF1A | 119263.628 | 6q22.31 | ASF1 anti-silencing function 1 homolog A (S. cerevisiae) |
| GJA1 | 121798.444 | 6q21-q23.2 | gap junction protein, alpha 1, 43kDa |
| HSF2 | 122762.494 | 6q22.31 | heat shock transcription factor 2 |
| SERINC1 | 122806.192 | 6q22.31 | serine incorporator 1 |
| PKIB | 122834.761 | 6q22.31 | protein kinase (cAMP-dependent, catalytic) inhibitor beta |
| FABP7 | 123142.345 | 6q22-q23 | fatty acid binding protein 7, brain |
| SMPDL3A | 123152.123 | 6q22.31 | sphingomyelin phosphodiesterase, acid-like 3A |
| NKAIN2 | 124166.768 | 6q21 | Na+/K+ transporting ATPase interacting 2 |
| STL | 125271.087 | 6q22.33 | Six-twelve leukemia gene |
| TPD52L1 | 125516.578 | 6q22-q23 | tumor protein D52-like 1 |
| HEY2 | 126112.425 | 6q21 | hairy/enhancer-of-split related with YRPW motif 2 |
| NCOA7 | 126144.000 | 6q22.31-q22.32 | nuclear receptor coactivator 7 |
| C6orf173 | 126702.971 | 6q22.32 | chromosome 6 open reading frame 173 |
| RNF146 | 127629.713 | 6q22.1-q22.33 | ring finger protein 146 |
| PTPRK | 128331.625 | 6q22.2-q22.3 | protein tyrosine phosphatase, receptor type, K |
| C12orf9 | 129938.970 | - | chromosome 12 open reading frame 9 |
| ARHGAP18 | 129939.934 | 6q22.33 | Rho GTPase activating protein 18 |
| AKAP7 | 131508.154 | 6q23 | A kinase (PRKA) anchor protein 7 |
| ARG1 | 131936.058 | 6q23 | arginase, liver |
| MED23 | 131936.801 | 6q22.33-q24.1 | mediator complex subunit 23 |
| ENPP3 | 132000.135 | 6q22 | ectonucleotide pyrophosphatase/phosphodiesterase 3 |
| ENPP1 | 132170.853 | 6q22-q23 | ectonucleotide pyrophosphatase/phosphodiesterase 1 |
| CTGF | 132311.012 | 6q23.1 | connective tissue growth factor |
| RPS12 | 133177.401 | 6q23.2 | ribosomal protein S12 |
| TCF21 | 134251.970 | 6pter-qter | transcription factor 21 |
| SGK1 | 134532.082 | 6q23 | serum/glucocorticoid regulated kinase 1 |
| MYB | 135544.146 | 6q22-q23 | v-myb myeloblastosis viral oncogene homolog (avian) |
| BCLAF1 | 136619.694 | 6q22-q23 | BCL2-associated transcription factor 1 |
| MAP3K5 | 136919.881 | 6q22.33 | mitogen-activated protein kinase kinase kinase 5 |
| IFNGR1 | 137560.315 | 6q23-q24 | interferon gamma receptor 1 |
| TNFAIP3 | 138230.274 | 6q23 | tumor necrosis factor, alpha-induced protein 3 |
| KIAA1244 | 138524.917 | 6q23.3 | KIAA1244 |
| PBOV1 | 138578.822 | 6q23-q24 | prostate and breast cancer overexpressed 1 |
| CCDC28A | 139136.350 | 6q23.1-q24.1 | coiled-coil domain containing 28A |
| REPS1 | 139267.314 | - | RALBP1 associated Eps domain containing 1 |
| HECA | 139497.942 | 6q23-q24 | headcase homolog (Drosophila) |
| CITED2 | 139735.092 | 6q23.3 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
| GAEC1 | 142495.989 | 7q22.1 | gene amplified in esophageal cancer 1 |
| AIG1 | 143423.716 | 6q24.2 | androgen-induced 1 |
| PLAGL1 | 144303.130 | 6q24-q25 | pleiomorphic adenoma gene-like 1 |
| UTRN | 144654.566 | 6q24 | utrophin |
| EPM2A | 145988.141 | 6q24 | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) |
| FBXO30 | 146160.967 | 6q24 | F-box protein 30 |
| SHPRH | 146247.637 | 6q24.3 | SNF2 histone linker PHD RING helicase |
| GRM1 | 146392.112 | 6q24 | glutamate receptor, metabotropic 1 |
| RAB32 | 146906.521 | 6q24.3 | RAB32, member RAS oncogene family |
| SASH1 | 148705.422 | 6q24.3 | SAM and SH3 domain containing 1 |
| UST | 149110.157 | 6q25.1 | uronyl-2-sulfotransferase |
| MAP3K7IP2 | 149680.756 | 6q25.1-q25.3 | mitogen-activated protein kinase kinase kinase 7 interacting protein 2 |
| ERVE1 | 149867.324 | 17q11 | endogenous retroviral sequence E, 1 |
| LATS1 | 150023.744 | 6q24-q25.1 | LATS, large tumor suppressor, homolog 1 (Drosophila) |
| PCMT1 | 150112.658 | 6q24-q25 | protein-L-isoaspartate (D-aspartate) O-methyltransferase |
| RAET1E | 150251.294 | 6q25.1 | retinoic acid early transcript 1E |
| ULBP2 | 150304.829 | 6q25 | UL16 binding protein 2 |
| PPP1R14C | 150505.881 | 6q24.3-q25.3 | protein phosphatase 1, regulatory (inhibitor) subunit 14C |
| IYD | 150731.721 | 6q25.1 | iodotyrosine deiodinase |
| MTHFD1L | 151228.384 | 6q25.1 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
| AKAP12 | 151688.516 | 6q24-q25 | A kinase (PRKA) anchor protein (gravin) 12 |
| ESR1 | 152170.379 | 6q25.1 | estrogen receptor 1 |
| MYCT1 | 153060.723 | 6q25.2 | myc target 1 |
| VIP | 153113.626 | 6q25 | vasoactive intestinal peptide |
| RGS17 | 153373.734 | 6q25.3 | regulator of G-protein signaling 17 |
| OPRM1 | 154402.136 | 6q24-q25 | opioid receptor, mu 1 |
| TIAM2 | 155453.115 | 6q25.2 | T-cell lymphoma invasion and metastasis 2 |
| NOX3 | 155758.196 | 6q25.1-q26 | NADPH oxidase 3 |
| SYNJ2 | 158322.907 | 6q25.3 | synaptojanin 2 |
| GTF2H5 | 158511.489 | 6q25.3 | general transcription factor IIH, polypeptide 5 |
| EZR | 159106.766 | 6q25.2-q26 | ezrin |
| FNDC1 | 159510.417 | 6q25 | fibronectin type III domain containing 1 |
| SOD2 | 160020.141 | 6q25.3 | superoxide dismutase 2, mitochondrial |
| WTAP | 160068.610 | 6q25-q27 | Wilms tumor 1 associated protein |
| ACAT2 | 160102.979 | 6q25.3 | acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase) |
| MAS1 | 160247.964 | 6q25.3-q26 |